44 related articles for article (PubMed ID: 2953248)
1. Skin irritation in transdermal drug delivery systems: a strategy for its reduction.
Kawahara K; Tojo K
Pharm Res; 2007 Feb; 24(2):399-408. PubMed ID: 17191093
[TBL] [Abstract][Full Text] [Related]
2. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations.
Gutierrez GE; Lalka D; Garrett IR; Rossini G; Mundy GR
Osteoporos Int; 2006; 17(7):1033-42. PubMed ID: 16758140
[TBL] [Abstract][Full Text] [Related]
3. Skin sensitivity and transdermal drug delivery. A review of the problem.
Carmichael AJ
Drug Saf; 1994 Feb; 10(2):151-9. PubMed ID: 8011180
[TBL] [Abstract][Full Text] [Related]
4. Controversy over use of pregnant mare's urine.
Clay SA
CMAJ; 1995 Jun; 152(11):1746-8. PubMed ID: 7773887
[No Abstract] [Full Text] [Related]
5. Transdermal oestradiol. A recent advance in oestrogen therapy.
Utian WH
Drugs; 1988 Oct; 36(4):383-6. PubMed ID: 3069434
[No Abstract] [Full Text] [Related]
6. Estrogen therapy during menopause. Practical treatment recommendations.
Sitruk-Ware R
Drugs; 1990 Feb; 39(2):203-17. PubMed ID: 2183999
[TBL] [Abstract][Full Text] [Related]
7. Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis.
Balfour JA; McTavish D
Drugs Aging; 1992; 2(6):487-507. PubMed ID: 1493353
[TBL] [Abstract][Full Text] [Related]
8. A risk-benefit appraisal of transdermal estradiol therapy.
Cheang A; Sitruk-Ware R; Utian WH
Drug Saf; 1993 Nov; 9(5):365-79. PubMed ID: 8280404
[TBL] [Abstract][Full Text] [Related]
9. Transdermal estradiol overall safety profile.
Utian WH
Am J Obstet Gynecol; 1987 May; 156(5):1335-8. PubMed ID: 2953248
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with transdermal estradiol in the treatment of the climacteric.
Utian WH
Minerva Endocrinol; 1989; 14(1):45-8. PubMed ID: 2543895
[TBL] [Abstract][Full Text] [Related]
11. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
Balfour JA; Heel RC
Drugs; 1990 Oct; 40(4):561-82. PubMed ID: 2083514
[TBL] [Abstract][Full Text] [Related]
12. Menorest: a clinical overview.
Wren B
Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S27-9. PubMed ID: 8666124
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms.
Place VA; Powers M; Darley PE; Schenkel L; Good WR
Am J Obstet Gynecol; 1985 Aug; 152(8):1092-9. PubMed ID: 2992278
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
